Timothy Pardee
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax (NCT07471841) | Timothy Pardee | 2026-07-01 |
Track Timothy Pardee automatically
Every clearance here is in the API, with alerts when new ones post.